PVP, TURP Outcomes Similar
Photoselective vaporization of the prostate (PVP) for BPH provides outcomes similar to those of transurethral resection of the prostate (TURP).
Diagnosis & Disease Information
Botulinum Toxin Could Be Useful As a BPH Treatment
Botulinum toxin type A (BTX-A) injections may be a promising treatment for BPH patients with urinary retention who are not candidates for surgery.
IPP May Aid BPH Management
Intravesical prostatic protrusion (IPP) is a useful predictor of outcomes in patients with BPH, studies show.
New Surgical Options for BPH Must Measure Up
The past two decades have witnessed the introduction a dizzying array of minimally-invasive surgical alternatives to the gold standard treatments for BPH—transurethral resection of the prostate (TURP) and the open simple prostatectomy.
New Blood Test Can Diagnose Severe BPH
Researchers have developed a new blood test that can distinguish severely symptomatic BPH from BPH that occurs with few if any symptoms, even if men have prostate cancer. The assay measures serum levels of a protein called JM-27.
Drug for Baldness Affects PSA Testing
As little as 1 mg/day of finasteride can seriously distort the results of a PSA screening for prostate cancer, a recent study has found.
Metabolic Syndrome and BPH
Prostate growth in men with benign prostatic hyperplasia (BPH) is increased in the presence of the metabolic syndrome, according to a study that supports a causative role for hyperinsulinemia.
Application and Study Protocol Accepted for BPH Drug
Spectrum Pharmaceuticals, Inc., of Irvine, Calif., has announced the FDA’s acceptance of its Investigational New Drug application for ozarelix for the treatment of benign prostatic hyperplasia (BPH) and approval of a phase IIb study of the drug.
Ethanol Injections Effective for Urinary Retention
Transurethral ethanol injection into the prostate (TUEIP) is an effective treatment for persistent urinary retention resulting from prostatic obstruction, according to a Japanese study.
Naftopidil Monotherapy Is Sufficient
Naftopidil is effective first-line monotherapy for patients with storage symptoms associated with benign prostatic hyperplasia (BPH), according to researchers in Japan.
- Loading...
Loading...
Loading... 
Loading...